Mebias Discovery Receives Grant from NIDA to Advance MEB‑1170 as an Analgesic Drug Candidate for the Prevention and Treatment of Opioid Use Disorder 
Grant to Fund IND Enabling and Phase 1 Clinical Trials

Preclinical Data Demonstrates MEB‑1170 Lacks Dangerous Side Effects Including Respiratory Depression and Opioid Abuse Potential

See more here